4/A//SEC Filing
IDEXX LABORATORIES INC /DE 4/A
Accession 0001140361-16-065979
$IDXXCIK 0000874716operating
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:26 PM ET
Size
30.7 KB
Accession
0001140361-16-065979
Insider Transaction Report
Form 4/AAmended
Williams Michael J
Corporate Vice President
Transactions
- Exercise/Conversion
Common Stock
2016-02-14+403→ 42,318 total - Award
Non-Qualified Stock Option (right-to-buy)
2016-02-14+41,259→ 41,259 totalExercise: $67.85Exp: 2026-02-13→ Common Stock (41,259 underlying) - Exercise/Conversion
Restricted Stock Unit
2016-02-14−545→ 14,740 total→ Common Stock (545 underlying) - Exercise/Conversion
Common Stock
2016-02-14−472→ 13,865 total→ Common Stock (472 underlying) - Tax Payment
Common Stock
2016-02-14$67.85/sh−779$52,855→ 42,011 total - Award
Incentive Stock Option (right-to-buy)
2016-02-14+1,476→ 1,476 totalExercise: $67.85→ Common Stock (1,476 underlying) - Exercise/Conversion
Common Stock
2016-02-14+514→ 40,856 total - Exercise/Conversion
Common Stock
2016-02-14+514→ 41,370 total - Exercise/Conversion
Common Stock
2016-02-14+545→ 41,915 total - Exercise/Conversion
Common Stock
2016-02-14+472→ 42,790 total - Award
Restricted Stock Unit
2016-02-14+3,685→ 16,313 total→ Common Stock (3,685 underlying) - Exercise/Conversion
Restricted Stock Unit
2016-02-14−514→ 15,799 total→ Common Stock (514 underlying) - Exercise/Conversion
Common Stock
2016-02-14−514→ 15,285 total→ Common Stock (514 underlying) - Exercise/Conversion
Common Stock
2016-02-14−403→ 14,337 total→ Common Stock (403 underlying)
Footnotes (11)
- [F1]Includes 84 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2015.
- [F10]Not applicable.
- [F11]Amendment filed to correct a typographical error in the previously reported number of stock options awarded.
- [F2]Closing price of Issuer's common stock on the NASDAQ market on February 12, 2016.
- [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017.
- [F4]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
- [F5]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
- [F6]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2013 and has been adjusted to reflect the Stock Split.
- [F7]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014 and has been adjusted to reflect the Stock Split.
- [F8]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split.
- [F9]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4/A
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:26 PM ET
- Size
- 30.7 KB